Subscribe
Home
Issues
Latest Issue
Issue Archive
Special Issues
Categories
Search ...
Personalized Medicine in Neurology
Should Whole-Exome Sequencing Be Integrated into Neurologic Care?
By
Chase Doyle
Personalized Medicine in Neurology
VBCN - May 2015 Volume 2, No 1
In a series of debates at the 2015 annual meeting of the American Academy of Neurology, expert physicians addressed current and controversial issues in neuroscience.
Read More
Precision Medicine in the Treatment of Epilepsy
By
Wayne Kuznar
Personalized Medicine in Neurology
VBCN - July 2014 Volume 1, No 2
Philadelphia, PA—Genomic sequencing is starting to yield progress in unraveling the genetics of select forms of epilepsy, with some immediate clinical implications, said David B. Goldstein, PhD, Professor of Molecular Genetics, Microbiology, and Biology, and Director of the Center for Human Genome Variation, Duke University, Durham, NC, at the 2014 meeting of the American Academy of Neurology.
Read More
Using Genomics in Clinical Practice in Neurology
By
Wayne Kuznar
Personalized Medicine in Neurology
VBCN - July 2014 Volume 1, No 2
Philadelphia, PA—Molecular subtyping and classification of patients for the selection of appropriate treatment and prognosis can now be used in routine clinical care in neurology, according to Teri Manolio, MD, PhD, Director, Division of Genomic Medicine, National Human Genome Research Institute, Rockville, MD, at the 2014 American Academy of Neurology meeting.
Read More
Growing Understanding of Genetic Causes of Progressive Myoclonic Epilepsies Improves the Diagnostic Workup
By
Caroline Helwick
Personalized Medicine in Neurology
VBCN - April 2014 Volume 1, No 1
The varied genetic causes of progressive myoclonic epilepsies (PMEs) are becoming better understood through genetic analyses. A team of Italian researchers recently contributed to the understanding of these rare diseases by defining the clinical spectrum and etiology of PMEs, using a database developed by the Genetics Commission of the Italian League against Epilepsy.
Read More
Novel Biomarker Panel May Predict Who Will Develop Cognitive Impairment, Including Alzheimer’s Disease
By
Rosemary Frei, MSc
Personalized Medicine in Neurology
VBCN - April 2014 Volume 1, No 1
A newly released study has found a set of 10 lipids from peripheral blood that can predict a neurodegenerative process that may be linked to Alzheimer’s disease (AD) or other types of cognitive impairment using a blood test to identify these biomarkers.
Read More
REST Regulates Neuronal Genes in the Aging Brain, Is Absent in AD
Personalized Medicine in Neurology
VBCN - April 2014 Volume 1, No 1
A new study by a team of researchers led by Bruce A. Yankner, MD, PhD, Professor of Genetics and Neurology, Harvard Medical School, Director of the Harvard Neurodegeneration Training Program, and Codirector of the Paul F. Glenn Laboratories for the Molecular Biology of Aging, has found that a gene regulating protein known as REST...
Read More
Search ...
Home
Issues
Latest Issue
Issue Archive
Special Issues
Categories
Subscribe to
Value-Based Care in Neurology
Stay up to date with personalized medicine by subscribing to recieve the free
VBCN
e‑Newsletter.
I'd like to recieve:
VBCN
e‑Newsletter
I have reviewed and consent to the terms of
VBCN
's
Privacy Policy
, and
VBCN
has my permission to retain my information in its database, and to forward pertinent communications to me.